tiprankstipranks
Trending News
More News >
D.N.A Biomedical Solutions Ltd (IL:DNA)
:DNA
Israel Market

Dna Group (DNA) Financial Statements

Compare
1 Followers

Dna Group Financial Overview

Dna Group's market cap is currently 915.65M. The company's EPS TTM is 0.179; its P/E ratio is 262.08; Dna Group is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in ILS

Dna Group Earnings and Revenue History

Dna Group Debt to Assets

Dna Group Cash Flow

Dna Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.